Gossamer Bio, Inc.
GOSS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $115 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $115 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $138 | $135 | $171 | $170 |
| G&A Expenses | $36 | $38 | $48 | $46 |
| SG&A Expenses | $36 | $38 | $48 | $46 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $10 | $0 | $0 |
| Operating Expenses | $175 | $184 | $219 | $216 |
| Operating Income | -$60 | -$184 | -$219 | -$216 |
| % Margin | -52.2% | – | – | – |
| Other Income/Exp. Net | $4 | $4 | -$11 | -$18 |
| Pre-Tax Income | -$56 | -$180 | -$229 | -$234 |
| Tax Expense | $1 | $0 | $0 | $0 |
| Net Income | -$57 | -$180 | -$229 | -$234 |
| % Margin | -49.3% | – | – | – |
| EPS | -0.25 | -0.8 | -2.84 | -3.33 |
| % Growth | 68.8% | 71.8% | 14.7% | – |
| EPS Diluted | -0.25 | -1.18 | -2.84 | -3.33 |
| Weighted Avg Shares Out | 226 | 226 | 85 | 75 |
| Weighted Avg Shares Out Dil | 226 | 226 | 85 | 75 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $2 | $1 |
| Interest Expense | $12 | $14 | $14 | $19 |
| Depreciation & Amortization | $4 | $4 | $4 | $5 |
| EBITDA | -$40 | -$162 | -$211 | -$209 |
| % Margin | -34.8% | – | – | – |